𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P13 DNA methylation in serum of breast cancer patients: An independent prognostic marker

✍ Scribed by H. Fiegl; H.M. Mueller; A. Widschwendter; L. Ivarsson; G. Goebel; E. Perkmann; C. Marth; M. Widschwendter

Book ID
118621893
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
139 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CDH1 and CDH13 methylation in serum is a
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients
✍ Andreas Widschwendter; Lennart Ivarsson; Anya Blassnig; Hannes M. MΓΌller; Heidi πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 74 KB

## Abstract Cervical cancer is the principal cause of death due to cancer in women. Five‐year survival rate ranges from 15–80%, depending on the extent of the disease. New predictive markers for relapse may increase survival rates by improving treatment of patients at high risk for relapse. The gen

Ribosomal DNA methylation in patients wi
Ribosomal DNA methylation in patients with endometrial carcinoma : An independent prognostic marker
✍ Matthew A. Powell; David G. Mutch; Janet S. Rader; Thomas J. Herzog; Tim Hui-Min πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 823 KB

## Abstract ## BACKGROUND Surgery is curative for the majority of patients with endometrial carcinoma: Consequently, the use of adjuvant therapy has been controversial. More effective methods to identify patients who are at risk for recurrence and who would benefit from adjuvant therapy are needed